Elite Pharmaceuticals, Inc.
OTC:ELTP
0.152 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 56.625 | 34,155.114 | 32.262 | 25.381 | 17.995 | 7.569 | 7.459 | 9.638 | 12.498 | 5.015 | 4.601 | 3.404 | 2.424 | 4.266 | 3.344 | 2.275 | 1.413 | 1.144 | 0.551 | 0.301 | 0.258 | 0.63 | 1.198 | 0.095 | 0.01 | 0.2 |
Cost of Revenue
| 31.648 | 17,561.093 | 17.467 | 13.514 | 10.016 | 4.701 | 3.511 | 5.898 | 4.484 | 3.014 | 3.236 | 2.315 | 1.014 | 2.675 | 2.306 | 1.465 | 1.025 | 0.831 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 24.977 | 16,594.021 | 14.795 | 11.867 | 7.979 | 2.868 | 3.948 | 3.739 | 8.014 | 2.002 | 1.365 | 1.088 | 1.41 | 1.591 | 1.039 | 0.81 | 0.389 | 0.313 | 0.551 | 0.301 | 0.258 | 0.63 | 1.198 | 0.095 | 0.01 | 0.2 |
Gross Profit Ratio
| 0.441 | 0.486 | 0.459 | 0.468 | 0.443 | 0.379 | 0.529 | 0.388 | 0.641 | 0.399 | 0.297 | 0.32 | 0.582 | 0.373 | 0.311 | 0.356 | 0.275 | 0.273 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 6.883 | 6,200.163 | 4.051 | 5.113 | 5.532 | 7.6 | 9.621 | 8.302 | 12.429 | 14.727 | 3.959 | 0.975 | 1.736 | 1.385 | 0.794 | 3.631 | 5.796 | 6.086 | 4.344 | 2.699 | 2.075 | 2.014 | 1.609 | 1.475 | 1.989 | 1.3 |
General & Administrative Expenses
| 7.305 | 5,122.272 | 4.478 | 3.336 | 3.412 | 3.22 | 2.577 | 2.441 | 3.237 | 3.164 | 2.189 | 1.559 | 1.41 | 0.876 | 1.841 | 2.147 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 7.305 | 5,122.272 | 4.478 | 3.336 | 3.412 | 3.22 | 2.577 | 2.441 | 3.237 | 3.164 | 2.189 | 1.559 | 1.41 | 0.876 | 1.841 | 2.147 | 2.435 | 2.535 | 2.63 | 3.169 | 2.55 | 1.858 | 0.764 | 0.777 | 0.985 | 0.6 |
Other Expenses
| -5.743 | 1,595.584 | 1.195 | 1.314 | 1.32 | 1.206 | 0.8 | 0.352 | 7.394 | 0.617 | 0.02 | 0.117 | 1.641 | 1.091 | 2.18 | 3.569 | 2.96 | 2.975 | 0 | 0 | 0 | 0 | 1.031 | 0.971 | 1.071 | 0.7 |
Operating Expenses
| 14.188 | 12,918.019 | 9.725 | 9.763 | 10.264 | 12.026 | 12.999 | 11.095 | 16.331 | 18.509 | 6.649 | 2.652 | 3.377 | 2.477 | 2.975 | 7.201 | 8.755 | 9.06 | 6.557 | 5.215 | 4.958 | 4.183 | 2.64 | 2.447 | 3.06 | 2 |
Operating Income
| 10.789 | 2,025.111 | 5.071 | 2.105 | -2.285 | -9.159 | -9.051 | -7.356 | -8.317 | -16.507 | -5.284 | -1.563 | -1.966 | -0.886 | -1.936 | -6.39 | -8.367 | -8.748 | -6.007 | -4.913 | -4.7 | -3.552 | -1.442 | -2.351 | -3.049 | -1.8 |
Operating Income Ratio
| 0.191 | 0.059 | 0.157 | 0.083 | -0.127 | -1.21 | -1.214 | -0.763 | -0.665 | -3.291 | -1.148 | -0.459 | -0.811 | -0.208 | -0.579 | -2.809 | -5.921 | -7.648 | -10.907 | -16.297 | -18.198 | -5.636 | -1.204 | -24.688 | -295.624 | -9 |
Total Other Income Expenses Net
| -10.326 | 1,960.763 | 1.234 | 2.04 | 0.047 | -0.449 | 4.65 | 9.525 | 7.394 | 45.721 | -90.684 | 3.528 | -12.922 | -11.507 | -5.86 | -0.211 | -2.607 | -3.102 | 0.219 | 0.206 | -1.626 | -0.449 | -0.508 | -12.08 | 0.073 | 0 |
Income Before Tax
| 0.463 | 3,985.874 | 6.304 | 4.145 | -2.238 | -9.955 | -4.719 | 1.944 | -1.203 | 28.926 | -96.868 | 1.134 | -15.542 | -13.884 | -8.057 | -6.602 | -10.91 | -11.812 | -6.883 | -5.906 | -6.513 | -4.133 | -1.91 | -14.329 | -2.976 | 0 |
Income Before Tax Ratio
| 0.008 | 0.117 | 0.195 | 0.163 | -0.124 | -1.315 | -0.633 | 0.202 | -0.096 | 5.768 | -21.052 | 0.333 | -6.411 | -3.254 | -2.409 | -2.902 | -7.721 | -10.327 | -12.499 | -19.59 | -25.221 | -6.557 | -1.595 | -150.441 | -288.53 | 0 |
Income Tax Expense
| -19.646 | -424.028 | -1.736 | -0.944 | 0.002 | -0.427 | -0.71 | -1.629 | -0.52 | -0.003 | -0.293 | -0.354 | -0.484 | -0.301 | 0.261 | 0.003 | 0.003 | 0.002 | 0.001 | 0.001 | 0.001 | -0.071 | -0.135 | -0.364 | 0 | -0.1 |
Net Income
| 20.109 | 4,409.902 | 8.898 | 5.088 | -2.24 | -9.279 | -3.673 | 3.811 | -0.683 | 28.93 | -96.575 | 1.488 | -15.058 | -13.582 | -8.057 | -6.605 | -13.893 | -11.804 | -6.884 | -5.907 | -6.514 | -4.061 | -1.775 | -13.965 | -2.976 | -1.7 |
Net Income Ratio
| 0.355 | 0.129 | 0.276 | 0.2 | -0.125 | -1.226 | -0.492 | 0.395 | -0.055 | 5.768 | -20.988 | 0.437 | -6.212 | -3.184 | -2.409 | -2.903 | -9.831 | -10.319 | -12.5 | -19.593 | -25.224 | -6.444 | -1.482 | -146.62 | -288.55 | -8.5 |
EPS
| 0.02 | 4.35 | 0.009 | 0.005 | -0.003 | -0.011 | -0.005 | 0.03 | -0.001 | 0.05 | -0.21 | 0.004 | -0.058 | -0.14 | -0.11 | -0.21 | -0.64 | -0.6 | -0.37 | -0.46 | -0.58 | -0.4 | -0.19 | -1.53 | -0.36 | -0.23 |
EPS Diluted
| 0.02 | 4.35 | 0.007 | 0.005 | -0.003 | -0.011 | -0.005 | -0.01 | -0.001 | -0.02 | -0.21 | 0.003 | -0.058 | -0.14 | -0.11 | -0.21 | -0.64 | -0.6 | -0.37 | -0.46 | -0.58 | -0.4 | -0.19 | -1.53 | -0.36 | -0.23 |
EBITDA
| 12.32 | 3,288.563 | 6.506 | 3.63 | -0.763 | -7.88 | -8.037 | -6.629 | -0.256 | -15.89 | -4.763 | -1.577 | -1.482 | -0.402 | -1.427 | -5.849 | -5.235 | -5.206 | -5.739 | -4.763 | -2.741 | -2.978 | -1.175 | -2.157 | -2.963 | -1.7 |
EBITDA Ratio
| 0.218 | 0.096 | 0.202 | 0.143 | -0.042 | -1.041 | -1.078 | -0.688 | -0.021 | -3.168 | -1.035 | -0.463 | -0.611 | -0.094 | -0.427 | -2.571 | -3.704 | -4.551 | -10.421 | -15.797 | -10.613 | -4.725 | -0.981 | -22.65 | -287.258 | -8.5 |